Avigen: Clinical Trials

4 trials sponsored by Avigen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Terminated 1
Phase 22Completed 1, Terminated 1

Follow Avigen: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AV650 Drug-Drug Interaction Study
AV650, Fluvoxamine, Paroxetine - Healthy
Phase 1CompletedAvigen302007-04-012007-09-17
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
AV411 - Diabetic Neuropathy
Phase 1 / Phase 2CompletedAvigen362006-09-012007-12-19
Study to Examine the Safety, Tolerability, and Pharmacokinetics of AV650
AV650 - Healthy Subjects
Phase 1CompletedAvigen302006-08-012007-02-28
Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
Adeno-Associated Viral with Human Factor IX - Hemophilia B
Phase 1 / Phase 2TerminatedAvigen152004-01-012007-04-04

Conditions studied

Diabetic Neuropathies (1)  ·  Hemophilia B (1)

Interventions

Fluvoxamine (1)  ·  Paroxetine (1)  ·  ibudilast (1)

Countries

United States (3)  ·  Australia (1)

Top investigators

Stephan A. Bart, M.D. (1)